An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis
- PMID: 17177178
- DOI: 10.1002/path.2119
An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis
Abstract
Pulmonary fibrosis is characterized by inflammation, genesis of myofibroblasts, and abnormal tissue repair. Despite extensive research, its pathogenesis remains incompletely understood. Previously, the transcription factor CCAAT/enhancer binding protein beta (C/EBPbeta) was found to be a key regulator of myofibroblast differentiation in vitro, and to be involved in the acute phase and inflammatory responses. In an attempt to test the role of C/EBPbeta in the development of pulmonary fibrosis, experiments using C/EBPbeta null mice and their wild-type littermates were conducted. Our findings indicated that, compared to wild-type mice, animals deficient in C/EBPbeta showed significantly reduced fibrotic lesions and collagen deposition in the lung upon endotracheal injection of bleomycin. Further studies on the mechanisms by which C/EBPbeta regulates fibrosis indicated that knockout of C/EBPbeta attenuates inflammatory cytokine expression in bleomycin-treated mice. The reduced alpha-smooth muscle actin gene expression in either isolated lung fibroblasts or lung tissue from bleomycin or saline-treated C/EBPbeta deficient mice suggests that C/EBPbeta regulates myofibroblast differentiation during fibrosis. Consistent with this finding, cells from C/EBPbeta deficient mice exhibited higher proliferative rates than those from wild-type mice. These data suggest that C/EBPbeta plays an essential role in pulmonary fibrosis and that this role appears to be multifactorial with respect to cytokine expression, cell differentiation, and proliferation.
Copyright (c) 2006 Pathological Society of Great Britain and Ireland.
Similar articles
-
Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia.J Neurochem. 2006 Sep;98(6):1718-31. doi: 10.1111/j.1471-4159.2006.04056.x. Epub 2006 Aug 8. J Neurochem. 2006. PMID: 16899075
-
Inhibition of activin receptor-like kinase 5 attenuates bleomycin-induced pulmonary fibrosis.Exp Mol Pathol. 2007 Aug;83(1):39-46. doi: 10.1016/j.yexmp.2006.12.003. Epub 2006 Dec 24. Exp Mol Pathol. 2007. PMID: 17274978
-
Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.J Immunol. 1999 May 1;162(9):5511-8. J Immunol. 1999. PMID: 10228032
-
The stroma reaction myofibroblast: a key player in the control of tumor cell behavior.Int J Dev Biol. 2004;48(5-6):509-17. doi: 10.1387/ijdb.041802ad. Int J Dev Biol. 2004. PMID: 15349825 Review.
-
The bone marrow leaves its scar: new concepts in pulmonary fibrosis.J Clin Invest. 2004 Jan;113(2):180-2. doi: 10.1172/JCI20782. J Clin Invest. 2004. PMID: 14722608 Free PMC article. Review.
Cited by
-
Role of Oxidative Stress-Dependent C/EBPβ Expression on CAF Transformation Inducing HCT116 Colorectal Cancer Cell Progression; Migration and Invasion.Asian Pac J Cancer Prev. 2023 Nov 1;24(11):3825-3835. doi: 10.31557/APJCP.2023.24.11.3825. Asian Pac J Cancer Prev. 2023. PMID: 38019240 Free PMC article.
-
Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis.Am J Pathol. 2011 Apr;178(4):1500-8. doi: 10.1016/j.ajpath.2011.01.002. Am J Pathol. 2011. PMID: 21435439 Free PMC article.
-
Detecting the Molecular System Signatures of Idiopathic Pulmonary Fibrosis through Integrated Genomic Analysis.Sci Rep. 2017 May 8;7(1):1554. doi: 10.1038/s41598-017-01765-6. Sci Rep. 2017. PMID: 28484236 Free PMC article.
-
Glucocorticoid regulation of the promoter of 11beta-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT/enhancer-binding protein-beta.Mol Endocrinol. 2008 Sep;22(9):2049-60. doi: 10.1210/me.2007-0489. Epub 2008 Jul 10. Mol Endocrinol. 2008. PMID: 18617597 Free PMC article.
-
CCAAT/enhancer-binding protein δ is a critical mediator of lipopolysaccharide-induced acute lung injury.Am J Pathol. 2013 Feb;182(2):420-30. doi: 10.1016/j.ajpath.2012.10.013. Epub 2012 Nov 21. Am J Pathol. 2013. PMID: 23177475 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases